Pancreatic neoplasm refers to abnormal growths that develop in the pancreas, a vital organ that helps with digestion and blood sugar control. Most of these tumors are cancerous and difficult to detect early, making pancreatic cancer one of the most challenging diseases to treat, with survival rates remaining low despite advances in medicine.
Epidemiology
Pancreatic cancer represents a significant health challenge worldwide. In the United States, it accounts for approximately three percent of all cancers but carries a disproportionately high mortality rate. It ranks as the tenth most common cancer in men and the eighth most common in women. However, its deadliness places it as the fourth leading cause of cancer deaths in the country.[1][2]
In 2014, an estimated 46,420 new cases were diagnosed in the United States, with 39,590 deaths occurring in the same year. The global burden is also substantial, with more than 331,000 deaths annually worldwide, ranking pancreatic cancer as the seventh principal cause of cancer death in both genders. These numbers reflect the aggressive nature of the disease and the challenges in early detection and treatment.[4]
Geographically, the disease shows variation in its occurrence. The highest incidence rates are found in Northern America, Western Europe, and Australia/New Zealand. The lowest rates occur in Middle Africa and South-Central Asia. For men specifically, Armenia, the Czech Republic, Slovakia, Hungary, Japan, and Lithuania show the greatest risk of developing pancreatic cancer. Among women, Northern America, Western Europe, Northern Europe, and Australia/New Zealand have the highest incidence rates, while Middle Africa and Polynesia have the lowest.[4]
A concerning trend is that cases of pancreatic cancer are on the rise. Current projections indicate that pancreatic cancer will become the second leading cause of cancer death in the United States by 2030. This upward trajectory underscores the urgent need for better prevention, detection, and treatment strategies.[2]
The five-year survival rate for pancreatic cancer remains dismal, ranging from five to fifteen percent in the United States, with an overall survival rate of only six percent. This poor prognosis is largely because most patients—approximately eighty percent—are diagnosed when the disease has already spread beyond the pancreas or has grown extensively in the local area. At the time of diagnosis, only twenty percent of pancreatic cancers are surgically removable, which is currently the only treatment option with curative potential.[1][4]
Causes
The exact cause of pancreatic cancer remains poorly understood, despite its high mortality rate. What researchers do know is that pancreatic cancer develops when cells in the pancreas undergo certain changes in their DNA (the genetic material that controls how cells function). These changes cause cells to grow and divide in an uncontrolled way, forming clusters called tumors. Most pancreatic cancers begin in the ducts (tubes) of the pancreas—the passages that carry digestive enzymes from the pancreas to the intestines.[1][6]
Pancreatic cancer is not typically an infectious disease, so it does not spread from person to person through contact or transmission routes like some other illnesses. Instead, it develops through internal cellular changes that accumulate over time. About ten percent of pancreatic cancers have a genetic cause, meaning they are associated with inherited genetic mutations or certain genetic syndromes that run in families.[4]
When cancer cells form in the pancreas, they can eventually spread beyond the organ if left untreated. These cells may migrate to other parts of the body, a process called metastasis. Understanding that these cellular changes drive the disease helps explain why prevention and early detection remain so challenging.[1]
Risk Factors
While the exact cause of pancreatic cancer is unclear, several factors can increase a person’s chances of developing the disease. It’s important to understand that having one or more risk factors does not mean someone will definitely get pancreatic cancer. Many people with risk factors never develop the disease, while some people with no known risk factors do get it.[6]
Smoking is recognized as one of the strongest risk factors for pancreatic cancer. About twenty percent of pancreatic cancers are caused by smoking cigarettes, cigars, or using other forms of tobacco. This is a modifiable risk factor, meaning people can reduce their risk by quitting or never starting to smoke.[1][4]
Age plays a significant role, with most pancreatic cancers diagnosed in people over 55 years old. The disease is also more common in certain demographic groups: men are at slightly higher risk than women, and African Americans have higher rates than white populations.[4]
Several health conditions increase risk. Diabetes (a condition where blood sugar levels are too high) is associated with pancreatic cancer, as is chronic pancreatitis (long-term inflammation of the pancreas). Cirrhosis (scarring) of the liver and infection with Helicobacter pylori, a bacterium that can cause stomach problems, also raise the risk.[4]
Lifestyle factors matter too. Obesity and carrying excess body weight increase the chances of developing pancreatic cancer. Lack of physical activity, high consumption of red meat, and drinking two or more soft drinks per day are possible risk factors, though the evidence for these is less definitive than for smoking or obesity. Heavy alcohol consumption and coffee drinking have also been studied as potential risk factors.[4][6]
Family history and genetics contribute significantly to risk. Having a family member with pancreatic cancer or pancreatitis increases the likelihood of developing the disease. About ten percent of pancreatic cancers have a genetic cause, linked to inherited genetic mutations or association with syndromes such as Lynch syndrome, Peutz-Jeghers syndrome, Von Hippel-Lindau syndrome, MEN1 (multiple endocrine neoplasia type 1), hereditary breast and ovarian cancer syndrome (involving BRCA1 and BRCA2 genes), and familial atypical multiple mole melanoma syndrome.[4][6]
Occupational exposure also matters. People who work with certain chemicals in the dry cleaning and metalworking industries face increased risk. If someone believes they might be at risk due to any of these factors, it’s important to discuss concerns with a doctor.[4]
Symptoms
One of the most challenging aspects of pancreatic cancer is that it rarely causes noticeable signs or symptoms in its early stages. This makes early detection extremely difficult. Symptoms typically only emerge once the tumor has grown large enough to affect other organs in the digestive system or has begun to spread.[1][6]
Jaundice, which is yellowing of the skin and the whites of the eyes, is one of the most common symptoms. This occurs when the tumor blocks the bile duct, preventing bile from flowing properly. Along with jaundice, patients may notice their urine becomes darker than usual and their stools (bowel movements) become lighter in color or appear pale.[2][6]
Pain is another frequent symptom. Many people experience discomfort in the upper or middle part of the abdomen (belly area) or in the middle of the back. This pain can come and go initially but may worsen after eating meals or when lying down. Some people report that back pain or stomach pain were their first noticeable symptoms, appearing up to one year before diagnosis.[2][6]
Digestive problems are common as well. Patients may experience nausea and vomiting, gas, bloating, and a persistent lack of appetite. These symptoms occur because the tumor interferes with normal digestive function. Weight loss often follows, happening without any deliberate effort to lose weight. This unintentional weight loss can be significant and alarming.[2][6]
Fatigue—feeling extremely tired even with adequate rest—affects many patients. Itchy skin can develop, particularly when jaundice is present, due to the buildup of substances in the bloodstream that normally would be eliminated through bile. Blood clots may form more easily in some patients with pancreatic cancer.[2]
New-onset diabetes or sudden worsening of existing diabetes can be a warning sign. Healthcare providers may suspect pancreatic cancer if a patient recently developed diabetes or pancreatitis (a painful condition caused by inflammation in the pancreas).[2]
It’s worth noting that pancreatic neuroendocrine tumors (a less common type of pancreatic tumor) may cause different symptoms than typical pancreatic cancer, such as diarrhea and anemia (low red blood cell count), and may not cause jaundice or weight loss.[2]
Because these symptoms can resemble many other, less serious conditions like ulcers or pancreatitis, pancreatic cancer often goes unrecognized until it has progressed. Anyone experiencing persistent or worsening symptoms should consult a healthcare provider for proper evaluation.[1]
Prevention
While pancreatic cancer cannot be completely prevented—since anyone with a pancreas has some risk—there are steps people can take to reduce their chances of developing the disease. Focusing on modifiable risk factors offers the best opportunity for prevention.[10]
The most impactful preventive measure is to avoid smoking or to quit if currently smoking. Since smoking causes about twenty percent of pancreatic cancers, eliminating tobacco use significantly reduces risk. This applies to cigarettes, cigars, and all forms of tobacco products.[4]
Maintaining a healthy weight is another important prevention strategy. Obesity increases the risk of pancreatic cancer, so achieving and sustaining a healthy body weight through balanced eating and regular physical activity can help lower risk. Being physically active has multiple health benefits and may contribute to reducing pancreatic cancer risk.[4][6]
Dietary choices matter. While the evidence is still developing, limiting consumption of red meat, avoiding excessive soft drink intake, and following a balanced diet rich in fruits, vegetables, and whole grains may help reduce risk. Moderating alcohol consumption is also advisable, as heavy drinking has been studied as a potential risk factor.[4]
For people with a family history of pancreatic cancer or known genetic mutations associated with the disease, genetic counseling and testing may be valuable. Those with hereditary conditions like Lynch syndrome, BRCA mutations, or other genetic syndromes that increase risk should discuss screening options with their healthcare providers. Early detection through screening may be recommended for high-risk individuals, though there are currently no standard screening tests for the general population.[4][6]
Managing underlying health conditions like chronic pancreatitis and diabetes with proper medical care may also play a role in risk reduction. People exposed to chemicals in certain occupations should follow safety protocols to minimize exposure to potentially harmful substances.[4]
Pathophysiology
Pathophysiology refers to the changes in normal bodily functions that occur when a disease develops. In pancreatic cancer, these changes begin at the cellular level and eventually affect how the entire organ and surrounding systems work.[1]
The pancreas is a gland about six inches long, shaped like a thin pear lying on its side. It sits in the abdomen between the stomach and spine. The pancreas has three main sections: the wider end is called the head, the middle section is the body, and the narrow end is the tail. This organ performs two essential jobs in the body: it produces digestive juices (enzymes) that help break down food, and it makes hormones like insulin and glucagon that help control blood sugar levels and how the body uses and stores energy.[6]
Pancreatic cancer can occur in two main types of cells. About ninety-five percent of pancreatic cancers begin in exocrine cells, which are the cells that produce digestive juices. The remaining cases start in endocrine cells, which produce hormones. Most pancreatic cancers are therefore exocrine tumors.[6]
Among exocrine tumors, over ninety percent are classified as exocrine tumors, and the most common type is adenocarcinoma, which accounts for about ninety percent of all pancreatic cancers. This type begins in the cells that line the pancreatic ducts—the tubes that carry digestive enzymes through the pancreas.[2][5]
Less common types of pancreatic tumors include acinar cell carcinoma, a very rare form that may cause excessive production of pancreatic lipase (an enzyme that digests fats). Another type is intraductal papillary-mucinous neoplasm (IPMN), which is a cystic tumor that grows from the main pancreatic duct or from side branches. An IPMN may be benign when first diagnosed but carries a risk of becoming malignant (cancerous), especially when it originates in the main duct. Mucinous cystadenocarcinoma is a rare, malignant tumor that forms a cyst filled with thick fluid called mucin, usually appearing in the tail of the pancreas and more commonly seen in women.[5]
The disease develops when small changes occur in the cellular DNA, causing cells to multiply in an uncontrolled way and accumulate in clusters that form tumors. If left untreated, cancer cells can break away from the original tumor and spread to other parts of the body through the bloodstream or lymphatic system.[1]
As the tumor grows, it disrupts normal pancreatic function. The pancreas may produce fewer digestive enzymes, leading to problems breaking down and absorbing food, particularly fats. This causes digestive difficulties, weight loss, and nutritional deficiencies. When tumors block the bile duct—a tube that carries bile from the liver through the pancreas to the intestines—bile cannot flow properly, causing jaundice and related symptoms.[2]
Early-stage pancreatic tumors typically don’t show up on imaging tests, which is why many people don’t receive a diagnosis until the cancer has grown large or spread to other organs. This spread, called metastasis, significantly complicates treatment. Pancreatic cancer is also notably resistant to many common cancer drugs, making it particularly difficult to treat even when detected.[2]
The location of the tumor within the pancreas matters for symptoms and treatment. Tumors in the head of the pancreas are more likely to block the bile duct early, causing jaundice and leading to earlier detection. Tumors in the body or tail may grow larger before causing noticeable symptoms, often resulting in later diagnosis.[17]
A particularly troubling aspect of pancreatic cancer pathophysiology is the high frequency of subclinical metastases—cancer cells that have spread but are too small to detect with current imaging technology. Even at the time of surgical removal, undetectable disease outside the pancreas is often present, which explains why many patients experience cancer recurrence even after apparently successful surgery.[14]
